| UniProt ID | TTYH3_HUMAN | |
|---|---|---|
| UniProt AC | Q9C0H2 | |
| Protein Name | Protein tweety homolog 3 | |
| Gene Name | TTYH3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 523 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
| Protein Description | Probable large-conductance Ca(2+)-activated chloride channel. May play a role in Ca(2+) signal transduction.. | |
| Protein Sequence | MAGVSYAAPWWVSLLHRLPHFDLSWEATSSQFRPEDTDYQQALLLLGAAALACLALDLLFLLFYSFWLCCRRRKSEEHLDADCCCTAWCVIIATLVCSAGIAVGFYGNGETSDGIHRATYSLRHANRTVAGVQDRVWDTAVGLNHTAEPSLQTLERQLAGRPEPLRAVQRLQGLLETLLGYTAAIPFWRNTAVSLEVLAEQVDLYDWYRWLGYLGLLLLDVIICLLVLVGLIRSSKGILVGVCLLGVLALVISWGALGLELAVSVGSSDFCVDPDAYVTKMVEEYSVLSGDILQYYLACSPRAANPFQQKLSGSHKALVEMQDVVAELLRTVPWEQPATKDPLLRVQEVLNGTEVNLQHLTALVDCRSLHLDYVQALTGFCYDGVEGLIYLALFSFVTALMFSSIVCSVPHTWQQKRGPDEDGEEEAAPGPRQAHDSLYRVHMPSLYSCGSSYGSETSIPAAAHTVSNAPVTEYMSQNANFQNPRCENTPLIGRESPPPSYTSSMRAKYLATSQPRPDSSGSH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 121 | Phosphorylation | GIHRATYSLRHANRT CHHHHHEHHHHCCCC | 17.99 | 24719451 | |
| 126 | N-linked_Glycosylation | TYSLRHANRTVAGVQ HEHHHHCCCCCCCCC | 33.75 | UniProtKB CARBOHYD | |
| 144 | N-linked_Glycosylation | WDTAVGLNHTAEPSL HHHCCCCCCCCCCCH | 25.24 | 19159218 | |
| 310 | Ubiquitination | AANPFQQKLSGSHKA CCCHHHHHCCCCHHH | 33.56 | - | |
| 312 | Phosphorylation | NPFQQKLSGSHKALV CHHHHHCCCCHHHHH | 45.33 | 28634298 | |
| 314 | Phosphorylation | FQQKLSGSHKALVEM HHHHCCCCHHHHHHH | 20.59 | 28634298 | |
| 316 | Ubiquitination | QKLSGSHKALVEMQD HHCCCCHHHHHHHHH | 45.15 | - | |
| 331 | Phosphorylation | VVAELLRTVPWEQPA HHHHHHHCCCCCCCC | 30.78 | 28634298 | |
| 337 (in isoform 3) | Ubiquitination | - | 30.31 | 21890473 | |
| 339 | Phosphorylation | VPWEQPATKDPLLRV CCCCCCCCCCCCCHH | 42.54 | 28634298 | |
| 340 | Ubiquitination | PWEQPATKDPLLRVQ CCCCCCCCCCCCHHH | 60.50 | - | |
| 351 | Phosphorylation | LRVQEVLNGTEVNLQ CHHHHHHCCCEEEHH | 61.59 | 17081983 | |
| 351 | N-linked_Glycosylation | LRVQEVLNGTEVNLQ CHHHHHHCCCEEEHH | 61.59 | 15010458 | |
| 437 | Phosphorylation | GPRQAHDSLYRVHMP CCCCCCHHHEECCCC | 19.89 | 23401153 | |
| 439 | Phosphorylation | RQAHDSLYRVHMPSL CCCCHHHEECCCCCH | 17.97 | 23403867 | |
| 445 | Phosphorylation | LYRVHMPSLYSCGSS HEECCCCCHHCCCCC | 32.15 | 27080861 | |
| 447 | Phosphorylation | RVHMPSLYSCGSSYG ECCCCCHHCCCCCCC | 13.27 | 27080861 | |
| 448 | Phosphorylation | VHMPSLYSCGSSYGS CCCCCHHCCCCCCCC | 19.80 | 27080861 | |
| 451 | Phosphorylation | PSLYSCGSSYGSETS CCHHCCCCCCCCCCC | 25.39 | 27080861 | |
| 452 | Phosphorylation | SLYSCGSSYGSETSI CHHCCCCCCCCCCCC | 20.85 | 27080861 | |
| 453 | Phosphorylation | LYSCGSSYGSETSIP HHCCCCCCCCCCCCC | 26.77 | 27080861 | |
| 455 | Phosphorylation | SCGSSYGSETSIPAA CCCCCCCCCCCCCCC | 29.48 | 27080861 | |
| 457 | Phosphorylation | GSSYGSETSIPAAAH CCCCCCCCCCCCCCC | 33.38 | 27080861 | |
| 458 | Phosphorylation | SSYGSETSIPAAAHT CCCCCCCCCCCCCCC | 23.64 | 27080861 | |
| 465 | Phosphorylation | SIPAAAHTVSNAPVT CCCCCCCCCCCCCHH | 22.39 | 27080861 | |
| 467 | Phosphorylation | PAAAHTVSNAPVTEY CCCCCCCCCCCHHHH | 28.56 | 27080861 | |
| 472 | Phosphorylation | TVSNAPVTEYMSQNA CCCCCCHHHHHCCCC | 21.97 | 25884760 | |
| 474 | Phosphorylation | SNAPVTEYMSQNANF CCCCHHHHHCCCCCC | 7.84 | 25884760 | |
| 476 | Phosphorylation | APVTEYMSQNANFQN CCHHHHHCCCCCCCC | 21.27 | 25884760 | |
| 476 | Ubiquitination | APVTEYMSQNANFQN CCHHHHHCCCCCCCC | 21.27 | 21890473 | |
| 476 (in isoform 2) | Ubiquitination | - | 21.27 | 21890473 | |
| 489 | Phosphorylation | QNPRCENTPLIGRES CCCCCCCCCCCCCCC | 9.36 | 30266825 | |
| 489 (in isoform 4) | Phosphorylation | - | 9.36 | 30266825 | |
| 496 | Phosphorylation | TPLIGRESPPPSYTS CCCCCCCCCCCCCCH | 41.15 | 23401153 | |
| 496 (in isoform 4) | Phosphorylation | - | 41.15 | 30266825 | |
| 500 | Phosphorylation | GRESPPPSYTSSMRA CCCCCCCCCCHHHHH | 46.98 | 23663014 | |
| 500 (in isoform 4) | Phosphorylation | - | 46.98 | 27732954 | |
| 501 | Phosphorylation | RESPPPSYTSSMRAK CCCCCCCCCHHHHHH | 19.20 | 30266825 | |
| 502 | Phosphorylation | ESPPPSYTSSMRAKY CCCCCCCCHHHHHHH | 20.75 | 30266825 | |
| 503 | Phosphorylation | SPPPSYTSSMRAKYL CCCCCCCHHHHHHHH | 17.57 | 30266825 | |
| 504 | Phosphorylation | PPPSYTSSMRAKYLA CCCCCCHHHHHHHHH | 12.42 | 30266825 | |
| 508 | Ubiquitination | YTSSMRAKYLATSQP CCHHHHHHHHHCCCC | 30.36 | 21890473 | |
| 508 (in isoform 1) | Ubiquitination | - | 30.36 | 21890473 | |
| 509 | Phosphorylation | TSSMRAKYLATSQPR CHHHHHHHHHCCCCC | 10.69 | 23927012 | |
| 512 | Phosphorylation | MRAKYLATSQPRPDS HHHHHHHCCCCCCCC | 25.87 | 22167270 | |
| 513 | Phosphorylation | RAKYLATSQPRPDSS HHHHHHCCCCCCCCC | 32.36 | 29255136 | |
| 517 (in isoform 4) | Ubiquitination | - | 53.14 | - | |
| 519 | Phosphorylation | TSQPRPDSSGSH--- CCCCCCCCCCCC--- | 39.00 | 30266825 | |
| 520 | Phosphorylation | SQPRPDSSGSH---- CCCCCCCCCCC---- | 52.25 | 30266825 | |
| 522 | Phosphorylation | PRPDSSGSH------ CCCCCCCCC------ | 28.15 | 29255136 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TTYH3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TTYH3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TTYH3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NEDD4_HUMAN | NEDD4 | physical | 18577513 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-144, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-519 AND SER-522, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522, AND MASSSPECTROMETRY. | |